About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Gestational Diabetes | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT04270578

Gestational Diabetes

Due to a changed lifestyle with less physical activity, unfavorable diets rich in fat and calories and obesity, the prevalence of diabetes mellitus is increasing worldwide. The diabetes epidemic is as...

Lead sponsor: University Hospital Tuebingen•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Andreas Fritsche, MD

CONTACT

+49 7071 29 andreas.fritsche@med.uni-tuebingen.de

Louise Fritsche, PhD

CONTACT

+49 7071 29 louise.fritsche@med.uni-tuebingen.de

Sponsors

Lead Sponsor

University Hospital Tuebingen

Collaborators

Deutsches Diabeteszentrum (DDZ), Leibniz-Institut Düsseldorf
Medizinische Klinik und Poliklinik III, Universitätsklinikum Carl Gustav Carus, TU Dresden
Klinik für Diabetologie an der Medizinischen Klinik - Innenstadt, LMU München
Universitätsklinik Heidelberg, Abteilung Innere Medizin I, Schwerpunkt Endokrinologie und Stoffwechsel
Universitätsklinikum Leipzig, IFB Adipositas Erkrankungen

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•\- Signed and dated informed consent
•Enrollment is possible during AND after gestation:
•Baseline visit (pregnancy): gestational week 24+0 till 31+6
•Postpartum visits: documented occurence of GDM in previous pregnancy

Exclusion Criteria

•Age \< 18years
•Diabetes Mellitus Type 1 or Type 2
•GFR \< 60 ml/min/1,73 m2
•CRP \> 1 mg/dl
•Increased levels of transaminases 2 fold above ULN
•Preexisting cardiac conditions
•Weight loss \> 10% within 6 months prior to inclusion
•Psychiatric disorders
•Chronic alcohol or substance abuse
•Blood sugar increasing or decreasing drug therapy, e.g. steroids, antidiabetics, insulin
•only postpartum visits: pregnancy or lactation

Related studies

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

RECRUITINGPhase 3

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes

NCT05569772 · Glucose Intolerance After a Recent History of Gestational Diabetes

Automated Insulin for Management of Intrapartum Glycemia

NCT06883344 · Type 1 Diabetes (T1D), Pregnancy, and more

Continuous Glucose Monitoring for Women With Gestational Diabetes

NCT06310356 · Gestational Diabetes

Pregnancy Cohort Study: Pregnancy as a Window to Future Health

NCT06925815 · Healthy Pregnant Women, Obese Pregnant Women, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 22, 2022Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment800

Start dateMay 2012

Last updatedAug 22, 2022

Condition

Gestational Diabetes

Locations shown

University Hospital Tuebingen

Tübingen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 22, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions